Integrated BioPharma, Inc. (INBP)
0.185
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Integrated BioPharma Total Long Term Debt (Quarterly) : 2.207M for March 31, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.207M |
| December 31, 2025 | 0.283M |
| September 30, 2025 | 0.332M |
| June 30, 2025 | 0.381M |
| March 31, 2025 | 0.299M |
| December 31, 2024 | 0.359M |
| September 30, 2024 | 0.604M |
| June 30, 2024 | 0.853M |
| March 31, 2024 | 1.104M |
| December 31, 2023 | 1.35M |
| September 30, 2023 | 1.598M |
| June 30, 2023 | 1.784M |
| March 31, 2023 | 2.021M |
| December 31, 2022 | 2.254M |
| September 30, 2022 | 1.971M |
| June 30, 2022 | 1.444M |
| March 31, 2022 | 1.489M |
| December 31, 2021 | 1.629M |
| September 30, 2021 | 1.88M |
| June 30, 2021 | 3.327M |
| March 31, 2021 | 5.181M |
| December 31, 2020 | 5.421M |
| September 30, 2020 | 5.706M |
| June 30, 2020 | 6.601M |
| March 31, 2020 | 5.262M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.63M |
| September 30, 2019 | 5.932M |
| June 30, 2019 | 6.591M |
| March 31, 2019 | 4.002M |
| December 31, 2018 | 3.98M |
| September 30, 2018 | 4.17M |
| June 30, 2018 | 9.666M |
| March 31, 2018 | 9.834M |
| December 31, 2017 | 9.997M |
| September 30, 2017 | 10.03M |
| June 30, 2017 | 10.58M |
| March 31, 2017 | 10.87M |
| December 31, 2016 | 10.88M |
| September 30, 2016 | 11.04M |
| June 30, 2016 | 11.45M |
| March 31, 2016 | 11.57M |
| December 31, 2015 | 9.683M |
| September 30, 2015 | 9.70M |
| June 30, 2015 | 9.781M |
| March 31, 2015 | 10.00M |
| December 31, 2014 | 10.14M |
| September 30, 2014 | 10.21M |
| June 30, 2014 | 10.67M |
| March 31, 2014 | 13.50M |
| December 31, 2013 | 14.43M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Medifast, Inc. | 22.46M |
| BioForce Nanosciences Holdings, Inc. | 0.00 |
| Skinvisible, Inc. | 5.724M |
| Nevis Brands, Inc. | -- |
| Skinhealth Systems, Inc. | 363.18M |